Skip to main content
Top
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Research

Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm

Authors: Kirsten Riches, Timothy G Angelini, Gurprit S Mudhar, Jean Kaye, Emily Clark, Marc A Bailey, Soroush Sohrabi, Sotirios Korossis, Peter G Walker, D Julian A Scott, Karen E Porter

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

Background

Vascular smooth muscle cells (SMC) are central to arterial structure and function yet their involvement in the progression of abdominal aortic aneurysm (AAA) disease is not well studied. The progressive and silent nature of AAA in man essentially restricts research to the use of “end-stage” tissue recovered during surgical repair. This study aimed to generate an ex vivo model of AAA using protease-treated porcine carotid arteries maintained in a novel bioreactor, and to compare the structural and functional changes in SMC cultured from the recovered vessels with those from human tissue acquired at elective surgical repair.

Methods

Freshly isolated porcine arteries were pretreated with collagenase and/or elastase before culturing under flow in a bioreactor for 12 days. Human end-stage aneurysmal tissue and saphenous veins from age-matched controls were collected from patients undergoing surgery. SMC were cultured and characterised (immunocytochemistry, measurement of spread cell area) and assessed functionally at the level of proliferation (cell-counting) and matrix-metalloproteinase (MMP) secretion (gelatin zymography). Cellular senescence was investigated using β-galactosidase staining and apoptosis was quantified using a fluorescence-based caspase 3 assay.

Results

Co-expression of alpha-smooth muscle actin and smooth muscle myosin heavy chain confirmed all cell populations as SMC. Porcine SMC harvested and cultivated after collagenase/elastase pretreatment displayed a prominent “rhomboid” morphology, increased spread area (32%, P < 0.01), impaired proliferation (47% reduction, P < 0.05), increased senescence (52%, P < 0.001), susceptibility to apoptosis and reduced MMP-2 secretion (60% decrease, P < 0.01) compared with SMC from vehicle, collagenase or elastase pre-treated vessels. Notably, these changes were comparable to those observed in human AAA SMC which were 2.4-fold larger than non-aneurysmal SMC (P < 0.001) and exhibited reduced proliferation (39% reduction, P < 0.001), greater apoptosis (4-fold increase, P < 0.001), and increased senescence (61%, P < 0.05).

Conclusions

Combined collagenase/elastase exposure of porcine artery maintained in a bioreactor under flow conditions induced a SMC phenotype characteristic of those cultured from end-stage AAA specimens. This model has potential and versatility to examine temporal changes in SMC biology and to identify the molecular mechanisms leading to early aberrancies in SMC function. In the longer term this may inform new targets to maintain aortic SMC content and drive cells to a “reparative” phenotype at early stages of the disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Filardo G, Powell JT, Martinez MA, Ballard DJ: Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database Syst Rev. 2012, 3: CD001835-PubMedCentralPubMed Filardo G, Powell JT, Martinez MA, Ballard DJ: Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database Syst Rev. 2012, 3: CD001835-PubMedCentralPubMed
2.
go back to reference Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM: Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. 2011, 8: 92-102. 10.1038/nrcardio.2010.180.CrossRefPubMed Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM: Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. 2011, 8: 92-102. 10.1038/nrcardio.2010.180.CrossRefPubMed
3.
go back to reference McCormick ML, Gavrila D, Weintraub NL: Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2007, 27: 461-469. 10.1161/01.ATV.0000257552.94483.14.CrossRefPubMed McCormick ML, Gavrila D, Weintraub NL: Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2007, 27: 461-469. 10.1161/01.ATV.0000257552.94483.14.CrossRefPubMed
4.
go back to reference Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004, 84: 767-801. 10.1152/physrev.00041.2003.CrossRefPubMed Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004, 84: 767-801. 10.1152/physrev.00041.2003.CrossRefPubMed
5.
go back to reference Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P: Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation. 1999, 99: 96-104. 10.1161/01.CIR.99.1.96.CrossRefPubMed Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P: Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation. 1999, 99: 96-104. 10.1161/01.CIR.99.1.96.CrossRefPubMed
6.
go back to reference Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, Lau CL, Owens GK: Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg. 2009, 138: 1392-1399. 10.1016/j.jtcvs.2009.07.075.PubMedCentralCrossRefPubMed Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, Lau CL, Owens GK: Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg. 2009, 138: 1392-1399. 10.1016/j.jtcvs.2009.07.075.PubMedCentralCrossRefPubMed
7.
go back to reference Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, Ghorpade A, Baxter BT: Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 1998, 18: 1625-1633. 10.1161/01.ATV.18.10.1625.CrossRefPubMed Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, Ghorpade A, Baxter BT: Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 1998, 18: 1625-1633. 10.1161/01.ATV.18.10.1625.CrossRefPubMed
8.
go back to reference Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002, 110: 625-632.PubMedCentralCrossRefPubMed Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002, 110: 625-632.PubMedCentralCrossRefPubMed
9.
go back to reference Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998, 102: 1900-1910. 10.1172/JCI2182.PubMedCentralCrossRefPubMed Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998, 102: 1900-1910. 10.1172/JCI2182.PubMedCentralCrossRefPubMed
10.
go back to reference Cafueri G, Parodi F, Pistorio A, Bertolotto M, Ventura F, Gambini C, Bianco P, Dallegri F, Pistoia V, Pezzolo A: Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition. PLoS One. 2012, 7: e35312-10.1371/journal.pone.0035312.PubMedCentralCrossRefPubMed Cafueri G, Parodi F, Pistorio A, Bertolotto M, Ventura F, Gambini C, Bianco P, Dallegri F, Pistoia V, Pezzolo A: Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition. PLoS One. 2012, 7: e35312-10.1371/journal.pone.0035312.PubMedCentralCrossRefPubMed
11.
go back to reference Gacchina C, Brothers T, Ramamurthi A: Evaluating smooth muscle cells from CaCl2-induced rat aortal expansions as a surrogate culture model for study of elastogenic induction of human aneurysmal cells. Tissue Eng Part A. 2011, 17: 1945-1958. 10.1089/ten.tea.2010.0475.PubMedCentralCrossRefPubMed Gacchina C, Brothers T, Ramamurthi A: Evaluating smooth muscle cells from CaCl2-induced rat aortal expansions as a surrogate culture model for study of elastogenic induction of human aneurysmal cells. Tissue Eng Part A. 2011, 17: 1945-1958. 10.1089/ten.tea.2010.0475.PubMedCentralCrossRefPubMed
12.
go back to reference Liao S, Curci JA, Kelley BJ, Sicard GA, Thompson RW: Accelerated replicative senescence of medial smooth muscle cells derived from abdominal aortic aneurysms compared to the adjacent inferior mesenteric artery. J Surg Res. 2000, 92: 85-95. 10.1006/jsre.2000.5878.CrossRefPubMed Liao S, Curci JA, Kelley BJ, Sicard GA, Thompson RW: Accelerated replicative senescence of medial smooth muscle cells derived from abdominal aortic aneurysms compared to the adjacent inferior mesenteric artery. J Surg Res. 2000, 92: 85-95. 10.1006/jsre.2000.5878.CrossRefPubMed
13.
go back to reference Goodall S, Crowther M, Hemingway DM, Bell PR, Thompson MM: Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation. 2001, 104: 304-309. 10.1161/01.CIR.104.3.304.CrossRefPubMed Goodall S, Crowther M, Hemingway DM, Bell PR, Thompson MM: Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation. 2001, 104: 304-309. 10.1161/01.CIR.104.3.304.CrossRefPubMed
14.
go back to reference Trollope A, Moxon JV, Moran CS, Golledge J: Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol. 2011, 20: 114-123. 10.1016/j.carpath.2010.01.001.CrossRefPubMed Trollope A, Moxon JV, Moran CS, Golledge J: Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol. 2011, 20: 114-123. 10.1016/j.carpath.2010.01.001.CrossRefPubMed
15.
go back to reference Allaire E, Muscatelli-Groux B, Mandet C, Guinault AM, Bruneval P, Desgranges P, Clowes A, Melliere D, Becquemin JP: Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg. 2002, 36: 1018-1026. 10.1067/mva.2002.127347.CrossRefPubMed Allaire E, Muscatelli-Groux B, Mandet C, Guinault AM, Bruneval P, Desgranges P, Clowes A, Melliere D, Becquemin JP: Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg. 2002, 36: 1018-1026. 10.1067/mva.2002.127347.CrossRefPubMed
16.
go back to reference Allaire E, Muscatelli-Groux B, Guinault AM, Pages C, Goussard A, Mandet C, Bruneval P, Melliere D, Becquemin JP: Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg. 2004, 239: 417-427. 10.1097/01.sla.0000114131.79899.82.PubMedCentralCrossRefPubMed Allaire E, Muscatelli-Groux B, Guinault AM, Pages C, Goussard A, Mandet C, Bruneval P, Melliere D, Becquemin JP: Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg. 2004, 239: 417-427. 10.1097/01.sla.0000114131.79899.82.PubMedCentralCrossRefPubMed
17.
go back to reference Hynecek RL, DeRubertis BG, Trocciola SM, Zhang H, Prince MR, Ennis TL, Kent KC, Faries PL: The creation of an infrarenal aneurysm within the native abdominal aorta of swine. Surgery. 2007, 142: 143-149. 10.1016/j.surg.2007.04.014.CrossRefPubMed Hynecek RL, DeRubertis BG, Trocciola SM, Zhang H, Prince MR, Ennis TL, Kent KC, Faries PL: The creation of an infrarenal aneurysm within the native abdominal aorta of swine. Surgery. 2007, 142: 143-149. 10.1016/j.surg.2007.04.014.CrossRefPubMed
18.
go back to reference Yazdani SK, Berry JL: Development of an in vitro system to assess stent-induced smooth muscle cell proliferation: a feasibility study. J Vasc Interv Radiol. 2009, 20: 101-106. 10.1016/j.jvir.2008.09.025.CrossRefPubMed Yazdani SK, Berry JL: Development of an in vitro system to assess stent-induced smooth muscle cell proliferation: a feasibility study. J Vasc Interv Radiol. 2009, 20: 101-106. 10.1016/j.jvir.2008.09.025.CrossRefPubMed
19.
go back to reference Touroo JS, Williams SK: A tissue-engineered aneurysm model for evaluation of endovascular devices. J Biomed Mater Res A. 2012, 100: 3189-3196.CrossRefPubMed Touroo JS, Williams SK: A tissue-engineered aneurysm model for evaluation of endovascular devices. J Biomed Mater Res A. 2012, 100: 3189-3196.CrossRefPubMed
20.
go back to reference Porter KE, Nydahl S, Dunlop P, Varty K, Thrush AJ, London NJ: The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia. Cardiovasc Res. 1996, 31: 607-614.CrossRefPubMed Porter KE, Nydahl S, Dunlop P, Varty K, Thrush AJ, London NJ: The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia. Cardiovasc Res. 1996, 31: 607-614.CrossRefPubMed
21.
go back to reference Porter KE, Varty K, Jones L, Bell PR, London NJ: Human saphenous vein organ culture: a useful model of intimal hyperplasia?. Eur J Vasc Endovasc Surg. 1996, 11: 48-58. 10.1016/S1078-5884(96)80134-1.CrossRefPubMed Porter KE, Varty K, Jones L, Bell PR, London NJ: Human saphenous vein organ culture: a useful model of intimal hyperplasia?. Eur J Vasc Endovasc Surg. 1996, 11: 48-58. 10.1016/S1078-5884(96)80134-1.CrossRefPubMed
22.
go back to reference Porter KE, Naik J, Turner NA, Dickinson T, Thompson MM, London NJ: Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg. 2002, 36: 150-157. 10.1067/mva.2002.122029.CrossRefPubMed Porter KE, Naik J, Turner NA, Dickinson T, Thompson MM, London NJ: Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg. 2002, 36: 150-157. 10.1067/mva.2002.122029.CrossRefPubMed
23.
go back to reference Madi HA, Riches K, Warburton P, O’Regan DJ, Turner NA, Porter KE: Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and type 2 diabetic patients. Am J Physiol Cell Physiol. 2009, 297: C1307-C1317. 10.1152/ajpcell.00608.2008.CrossRefPubMed Madi HA, Riches K, Warburton P, O’Regan DJ, Turner NA, Porter KE: Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and type 2 diabetic patients. Am J Physiol Cell Physiol. 2009, 297: C1307-C1317. 10.1152/ajpcell.00608.2008.CrossRefPubMed
24.
go back to reference Hao H, Gabbiani G, Bochaton-Piallat ML: Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol. 2003, 23: 1510-1520. 10.1161/01.ATV.0000090130.85752.ED.CrossRefPubMed Hao H, Gabbiani G, Bochaton-Piallat ML: Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol. 2003, 23: 1510-1520. 10.1161/01.ATV.0000090130.85752.ED.CrossRefPubMed
25.
go back to reference Sanz-Gonzalez SM, Poch E, Perez-Roger I, Diez-Juan A, Ivorra C, Andres V: Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease. Front Biosci. 2000, 5: D619-D628. 10.2741/sanz.CrossRefPubMed Sanz-Gonzalez SM, Poch E, Perez-Roger I, Diez-Juan A, Ivorra C, Andres V: Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease. Front Biosci. 2000, 5: D619-D628. 10.2741/sanz.CrossRefPubMed
26.
go back to reference Dai J, Michineau S, Franck G, Desgranges P, Becquemin JP, Gervais M, Allaire E: Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction. PLoS One. 2011, 6: e28903-10.1371/journal.pone.0028903.PubMedCentralCrossRefPubMed Dai J, Michineau S, Franck G, Desgranges P, Becquemin JP, Gervais M, Allaire E: Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction. PLoS One. 2011, 6: e28903-10.1371/journal.pone.0028903.PubMedCentralCrossRefPubMed
27.
go back to reference Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW: Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol. 1997, 150: 993-1007.PubMedCentralPubMed Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW: Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol. 1997, 150: 993-1007.PubMedCentralPubMed
28.
go back to reference Patel MI, Ghosh P, Melrose J, Appleberg M: Smooth muscle cell migration and proliferation is enhanced in abdominal aortic aneurysms. Aust N Z J Surg. 1996, 66: 305-308. 10.1111/j.1445-2197.1996.tb01192.x.CrossRefPubMed Patel MI, Ghosh P, Melrose J, Appleberg M: Smooth muscle cell migration and proliferation is enhanced in abdominal aortic aneurysms. Aust N Z J Surg. 1996, 66: 305-308. 10.1111/j.1445-2197.1996.tb01192.x.CrossRefPubMed
29.
go back to reference Al-Shawaf E, Naylor J, Taylor H, Riches K, Milligan CJ, O’Regan D, Porter KE, Li J, Beech DJ: Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2010, 30: 1453-1459. 10.1161/ATVBAHA.110.205666.PubMedCentralCrossRefPubMed Al-Shawaf E, Naylor J, Taylor H, Riches K, Milligan CJ, O’Regan D, Porter KE, Li J, Beech DJ: Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2010, 30: 1453-1459. 10.1161/ATVBAHA.110.205666.PubMedCentralCrossRefPubMed
30.
go back to reference Maqbool A, Turner NA, Galloway S, Riches K, O’Regan DJ, Porter KE: The-1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patients. Atherosclerosis. 2009, 207: 458-465. 10.1016/j.atherosclerosis.2009.05.028.CrossRefPubMed Maqbool A, Turner NA, Galloway S, Riches K, O’Regan DJ, Porter KE: The-1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patients. Atherosclerosis. 2009, 207: 458-465. 10.1016/j.atherosclerosis.2009.05.028.CrossRefPubMed
31.
go back to reference Turner NA, Ho S, Warburton P, O’Regan DJ, Porter KE: Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells. J Vasc Surg. 2007, 45: 1022-1028. 10.1016/j.jvs.2007.01.061.CrossRefPubMed Turner NA, Ho S, Warburton P, O’Regan DJ, Porter KE: Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells. J Vasc Surg. 2007, 45: 1022-1028. 10.1016/j.jvs.2007.01.061.CrossRefPubMed
32.
go back to reference Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB: The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res. 2012, 95: 194-204. 10.1093/cvr/cvs135.CrossRefPubMed Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB: The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res. 2012, 95: 194-204. 10.1093/cvr/cvs135.CrossRefPubMed
33.
go back to reference Kotsis V, Stabouli S, Karafillis I, Nilsson P: Early vascular aging and the role of central blood pressure. J Hypertens. 2011, 29: 1847-1853. 10.1097/HJH.0b013e32834a4d9f.CrossRefPubMed Kotsis V, Stabouli S, Karafillis I, Nilsson P: Early vascular aging and the role of central blood pressure. J Hypertens. 2011, 29: 1847-1853. 10.1097/HJH.0b013e32834a4d9f.CrossRefPubMed
34.
go back to reference Atturu G, Brouilette S, Samani NJ, London NJ, Sayers RD, Bown MJ: Short leukocyte telomere length is associated with abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2010, 39: 559-564. 10.1016/j.ejvs.2010.01.013.CrossRefPubMed Atturu G, Brouilette S, Samani NJ, London NJ, Sayers RD, Bown MJ: Short leukocyte telomere length is associated with abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2010, 39: 559-564. 10.1016/j.ejvs.2010.01.013.CrossRefPubMed
35.
go back to reference Orlandi A, Bochaton-Piallat ML, Gabbiani G, Spagnoli LG: Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis. 2006, 188: 221-230. 10.1016/j.atherosclerosis.2006.01.018.CrossRefPubMed Orlandi A, Bochaton-Piallat ML, Gabbiani G, Spagnoli LG: Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis. 2006, 188: 221-230. 10.1016/j.atherosclerosis.2006.01.018.CrossRefPubMed
36.
go back to reference Kazi M, Zhu C, Roy J, Paulsson-Berne G, Hamsten A, Swedenborg J, Hedin U, Eriksson P: Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2005, 25: 1341-1346. 10.1161/01.ATV.0000166601.49954.21.CrossRefPubMed Kazi M, Zhu C, Roy J, Paulsson-Berne G, Hamsten A, Swedenborg J, Hedin U, Eriksson P: Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2005, 25: 1341-1346. 10.1161/01.ATV.0000166601.49954.21.CrossRefPubMed
37.
go back to reference Irizarry E, Newman KM, Gandhi RH, Nackman GB, Halpern V, Wishner S, Scholes JV, Tilson MD: Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res. 1993, 54: 571-574. 10.1006/jsre.1993.1087.CrossRefPubMed Irizarry E, Newman KM, Gandhi RH, Nackman GB, Halpern V, Wishner S, Scholes JV, Tilson MD: Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res. 1993, 54: 571-574. 10.1006/jsre.1993.1087.CrossRefPubMed
38.
go back to reference Thompson M, Cockerill G: Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis. Ann N Y Acad Sci. 2006, 1085: 170-174. 10.1196/annals.1383.034.CrossRefPubMed Thompson M, Cockerill G: Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis. Ann N Y Acad Sci. 2006, 1085: 170-174. 10.1196/annals.1383.034.CrossRefPubMed
39.
go back to reference Crowther M, Goodall S, Jones JL, Bell PR, Thompson MM: Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg. 2000, 32: 575-583. 10.1067/mva.2000.108010.CrossRefPubMed Crowther M, Goodall S, Jones JL, Bell PR, Thompson MM: Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg. 2000, 32: 575-583. 10.1067/mva.2000.108010.CrossRefPubMed
40.
go back to reference Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995, 15: 1145-1151. 10.1161/01.ATV.15.8.1145.CrossRefPubMed Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995, 15: 1145-1151. 10.1161/01.ATV.15.8.1145.CrossRefPubMed
41.
go back to reference Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms: the UK small aneurysm trial participants. Lancet. 1998, 352: 1649-1655. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms: the UK small aneurysm trial participants. Lancet. 1998, 352: 1649-1655.
42.
go back to reference Petersen E, Gineitis A, Wagberg F, Angquist KA: Activity of matrix metalloproteinase-2 and-9 in abdominal aortic aneurysms: relation to size and rupture. Eur J Vasc Endovasc Surg. 2000, 20: 457-461. 10.1053/ejvs.2000.1211.CrossRefPubMed Petersen E, Gineitis A, Wagberg F, Angquist KA: Activity of matrix metalloproteinase-2 and-9 in abdominal aortic aneurysms: relation to size and rupture. Eur J Vasc Endovasc Surg. 2000, 20: 457-461. 10.1053/ejvs.2000.1211.CrossRefPubMed
43.
go back to reference Papalambros E, Sigala F, Georgopoulos S, Menekakos C, Giatromanolaki A, Bastounis E, Sivridis E: Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter. Int J Mol Med. 2003, 12: 965-968.PubMed Papalambros E, Sigala F, Georgopoulos S, Menekakos C, Giatromanolaki A, Bastounis E, Sivridis E: Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter. Int J Mol Med. 2003, 12: 965-968.PubMed
44.
go back to reference Multicentre Aneurysm Screening Study Group: Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ. 2002, 325: 1135-10.1136/bmj.325.7373.1135.PubMedCentralCrossRef Multicentre Aneurysm Screening Study Group: Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ. 2002, 325: 1135-10.1136/bmj.325.7373.1135.PubMedCentralCrossRef
45.
go back to reference Thompson SG, Ashton HA, Gao L, Scott RA: Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised multicentre aneurysm screening study. BMJ. 2009, 338: b2307-10.1136/bmj.b2307.PubMedCentralCrossRefPubMed Thompson SG, Ashton HA, Gao L, Scott RA: Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised multicentre aneurysm screening study. BMJ. 2009, 338: b2307-10.1136/bmj.b2307.PubMedCentralCrossRefPubMed
Metadata
Title
Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm
Authors
Kirsten Riches
Timothy G Angelini
Gurprit S Mudhar
Jean Kaye
Emily Clark
Marc A Bailey
Soroush Sohrabi
Sotirios Korossis
Peter G Walker
D Julian A Scott
Karen E Porter
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-208

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine